Lenacapavir for HIV Prevention in South Africa
South Africa will introduce lenacapavir for HIV prevention in 2026, offering a new hope in the fight against HIV.
HIV/AIDS Funding Gap: Government Steps In
The South African government has stepped in with a crucial R753.5 million injection from the National Treasury to sustain the nation’s HIV/Aids programmes. This vital funding seeks to close the HIV/AIDS funding gap. The withdrawal of the United States President’s Emergency Plan for AIDS Relief (PEPFAR) significantly impacted this gap. This move had threatened to…...
Global Health Giants Consider Merger Amidst Funding Crunch
Examine the significance of collaboration between the Global Fund and Gavi in responding to the global health financing crisis.
HIV/AIDS Programme Remains Strong Amid Funding Cuts
Discover how South Africa's HIV/AIDS programme is adapting after US funding cuts. The programme remains on solid ground.
SA confident of HIV treatment goals despite aid cuts
Motsoaledi assures Parliament that the nation remains on track to meet its HIV treatment targets despite cuts in US aid, showing the country's self-reliance.
Global fund affirms commitment to lenacapavir rollout
The Global Fund for HIV, TB, and Malaria reaffirms its commitment to introducing the twice-yearly HIV prevention jab, lenacapavir, in underprivileged countries.